rs16890979 — SLC2A9

SLC2A9 Val282Ile — A Protective Urate Transport Variant

Your kidneys filter roughly 700 mg of uric acid per day, and the majority of it is reabsorbed back into your bloodstream before it reaches the urine. The gene SLC2A9 encodes GLUT9¹¹ GLUT9
Glucose Transporter 9, a high-capacity urate transporter expressed in the proximal tubule of the kidney that mediates urate reabsorption, the protein responsible for most of that reabsorption. A common missense variant in this gene — rs16890979, causing a valine-to-isoleucine substitution at position 282 — modestly impairs this reabsorption, resulting in more urate being excreted in the urine and lower levels remaining in the blood.

This variant is one of two independent functional changes studied in the SLC2A9 gene alongside rs3733591 (Arg265His), and the two act on the transporter through distinct structural positions. While rs3733591 is the larger-effect risk variant in East Asian populations, rs16890979 provides a modest but measurable protective effect in both Caucasian and Asian individuals carrying the T allele.

The Mechanism

The c.844G>A substitution on the SLC2A9 coding strand (minus strand of chromosome 4) replaces a valine at position 282 of the GLUT9a long isoform (position 253 in the GLUT9b short isoform) with an isoleucine. Both isoforms are expressed in the kidney proximal tubule — GLUT9a (long isoform) on the basolateral membrane mediating reabsorption from the interstitium, and GLUT9b (short isoform) on the apical membrane.

A kidney organoid study by Xuan et al.²² kidney organoid study by Xuan et al.
Xuan et al. SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids. Front Cell Dev Biol, 2024 demonstrated that organoids carrying the rs16890979 mutation showed significantly reduced uric acid absorption compared to wild-type. Molecular docking revealed a slight decrease in the affinity between the GLUT9 Val282Ile variant and uric acid, though the authors note that multiple mechanisms likely contribute to the reduced transport function. Complementary experiments showed that GLUT9 overexpression increases uric acid absorption and GLUT9 knockdown reduces it, confirming GLUT9's central role in renal urate handling.

The net effect of the T allele is reduced reabsorption of urate from the tubular fluid — the transporter is less efficient — meaning more urate reaches the urine and serum levels are modestly lower.

The Evidence

Gout association meta-analysis: A meta-analysis by Lee et al.³³ meta-analysis by Lee et al.
Lee YH et al. Associations between SLC2A9 polymorphisms and gout susceptibility. Z Rheumatol, 2016 pooling 11 studies comprising 1,472 gout cases and 3,269 controls found that the minor allele of rs16890979 was significantly associated with reduced gout risk across all study subjects (OR = 0.229, 95% CI 0.084–0.628, p = 0.004). In Caucasians, the protective OR was 0.469; in Asians, it was 0.192 — suggesting stronger protection in Asian populations where the minor allele is rarer and the genetic contrast is sharper. Notably, no gout cases with the homozygous minor genotype were found, consistent with the very low T allele frequency in Asian populations (~1%) and the strong protection it confers.

Functional confirmation in organoids: The kidney organoid model published in 2024 confirmed the biological basis for this protection, showing directly that the rs16890979 variant reduces uric acid absorption at the cellular level. This mechanistic confirmation strengthens the GWAS and case-control epidemiology.

Allele frequency paradox: A notable complexity of this variant is the striking population frequency difference: the T allele is very rare in East Asians (~1%), present at moderate frequency in Europeans (~18%), and common in African (~44%) and Latino (~40%) populations. The high frequency in African-ancestry populations likely reflects the ancestral state of human urate metabolism — humans lost uricase⁴⁴ humans lost uricase
the enzyme that breaks down uric acid to allantoin — about 15 million years ago, a genetic event that elevated baseline serum urate levels relative to other primates. The protective T allele may represent a partial compensation for this evolutionary loss, maintained at high frequency in some populations.

The apparent contradiction between the variant's high frequency in Africans (where uric acid-related disease is less prominent historically) and its protective status in gout meta-analyses reflects the multi-factorial nature of gout — dietary patterns, metabolic co-morbidities, and other genetic loci all interact with SLC2A9 genotype.

Independence from rs3733591: rs16890979 (Val282Ile) affects a different structural position in the GLUT9 protein than rs3733591 (Arg265His). The two variants have been treated as independent effects in the gout genetics literature, with rs16890979 providing a protective signal independent of the rs3733591 risk signal. They are not in strong linkage disequilibrium given their opposite effects on serum urate and distinct allele frequency profiles.

Practical Actions

The T allele of rs16890979 provides a modest head start on urate clearance, but this advantage is not large enough to override dietary and lifestyle factors. Serum uric acid above 6.8 mg/dL leads to crystal formation regardless of genotype. For CT and TT carriers, the main implication is that their kidneys are somewhat more efficient at clearing urate — monitoring may be less urgent and the threshold for dietary intervention somewhat higher than for rs3733591 C allele carriers.

The most potent dietary modulators of uric acid remain: purine load (organ meats, red meat, shellfish, anchovies), alcohol especially beer and spirits (which elevate urate both by providing purine substrates and by competing with urate for renal excretion), and fructose intake (high-fructose corn syrup beverages and fruit juice are particularly potent drivers). Low-fat dairy and coffee consumption are both associated with modestly lower serum urate and are reasonable dietary choices for anyone with borderline urate levels.

Adequate hydration (2–3 litres per day) supports urate excretion and is especially important for anyone with a history of kidney stones, which can be composed of uric acid crystals.

Interactions

With rs3733591 (SLC2A9 Arg265His): These two SLC2A9 variants occupy different positions in the GLUT9 protein. Rs3733591 is the larger-effect variant, with the C allele adding ~0.65 mg/dL of serum urate per copy. The Val282Ile (rs16890979) T allele provides a modest offsetting protective effect. In individuals who carry both variants — for example, CT at rs3733591 and CT at rs16890979 — the two effects partially counterbalance, though the rs3733591 C allele effect likely dominates. Compound interpretation requires examining both loci.

With ABCG2 rs2231142 (Q141K): ABCG2 reduces intestinal urate secretion (gut efflux pathway), while SLC2A9 controls renal reabsorption. The rs16890979 T allele's renal protection does not offset an ABCG2 rs2231142 A allele, which eliminates the gut excretion pathway. Individuals with T allele at rs16890979 but A allele at ABCG2 rs2231142 still face elevated urate from the intestinal side.

With fructose intake: Fructose metabolism generates urate precursors and competing anions that reduce renal urate excretion. Even carriers of the protective T allele should limit high-fructose corn syrup and concentrated fruit juice, as fructose overload can overcome the partial advantage from reduced tubular reabsorption.